Bio-Thera Solutions (02315.HK) -1.140 (-2.235%) Short selling $1.03M; Ratio 3.369% announced that for 1Q26, revenue prepared under the China Accounting Standards amounted to approximately RMB433 million, representing a YoY increase of 73.68%. Net profit attributable to shareholders of the listed company was approximately RMB104 million, compared with a loss of RMB13.2458 million in the same period last year. Basic EPS was RMB0.23.
AASTOCKS Financial News